| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Antonino Nicoletti | Q44231209 |
| Giuseppina Caligiuri | Q58924258 | ||
| P2093 | author name string | G K Hansson | |
| P2860 | cites work | Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 |
| Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells | Q28509783 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study | Q29615116 | ||
| Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 | ||
| Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury | Q33564406 | ||
| Low density lipoprotein undergoes oxidative modification in vivo | Q33838672 | ||
| Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions | Q33848520 | ||
| Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E | Q33962949 | ||
| T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein | Q34390132 | ||
| Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis | Q34541589 | ||
| Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis | Q34737721 | ||
| Composition and classification of human atherosclerotic lesions | Q35433689 | ||
| Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet | Q35824745 | ||
| Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis | Q36028683 | ||
| T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse | Q36142970 | ||
| Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation | Q36347058 | ||
| Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation | Q36355346 | ||
| Delayed hematopoietic development in osteopetrotic (op/op) mice | Q36361203 | ||
| Manipulating the Immune System with Immune Globulin | Q36725772 | ||
| Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma | Q37358413 | ||
| IFN-gamma potentiates atherosclerosis in ApoE knock-out mice | Q37368296 | ||
| The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice | Q37372718 | ||
| Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases | Q37433060 | ||
| Viruses in the etiology of atherosclerosis | Q37618389 | ||
| Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease | Q37881093 | ||
| Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease | Q37881317 | ||
| Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot profile | Q37881987 | ||
| Lymphocyte responses to Chlamydia antigens in patients with coronary heart disease | Q37882557 | ||
| Murine models of Chlamydia pneumoniae infection and atherosclerosis | Q37883205 | ||
| Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy | Q37885296 | ||
| Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries | Q37891287 | ||
| Heat shock proteins and the immune response | Q37923407 | ||
| Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice | Q39802780 | ||
| Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. | Q39808657 | ||
| Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis | Q40137011 | ||
| Molecular bases of the acute coronary syndromes | Q40530238 | ||
| Is atherosclerosis an immunologically mediated disease? | Q40606541 | ||
| V region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (i.v.Ig). | Q40633384 | ||
| Stress proteins and atherosclerosis | Q41449793 | ||
| Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes | Q46133692 | ||
| Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis | Q47788311 | ||
| Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities | Q48501090 | ||
| Association of virulent Helicobacter pylori strains with ischemic heart disease. | Q50887983 | ||
| Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentrations and degree of coronary artery disease. | Q50892428 | ||
| Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. | Q51012002 | ||
| Cyclosporine A Inhibits Induction of DNA Synthesis by PDGF and Other Peptide Mitogens in Cultured Rat Aortic Smooth Muscle Cells and Dermal Fibroblasts | Q54200968 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 397-405 | |
| P577 | publication date | 2000-03-01 | |
| P1433 | published in | Journal of Internal Medicine | Q6295387 |
| P1476 | title | Immunomodulation of atherosclerosis: myth and reality | |
| P478 | volume | 247 |
| Q80232964 | Calcium distribution in the vessel wall and intima-media thickness of the human carotid arteries |
| Q78594580 | Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease |
| Q51315448 | Effect of flaxseed on choroid-sclera complex thickness and on LDL oxidation in the sclera, choroid and retina of diet-induced hypercholesterolaemic rabbits. |
| Q35172183 | Immunomodulation for treatment and prevention of atherosclerosis |
| Q33184773 | MCMV infection increases early T-lymphocyte influx in atherosclerotic lesions in apoE knockout mice |
| Q37806960 | Oxidative mechanisms and atherothrombotic cardiovascular disease |
| Q45083057 | Role of apolipoprotein E in renal damage protection |
| Q31079034 | Screening of a HUAEC cDNA library identifies actin as a candidate autoantigen associated with carotid atherosclerosis |
| Q37364515 | The relationship between brachial ankle pulse wave velocity and complement 1 inhibitor |
| Q82893705 | [Immunological aspects of atherosclerosis] |
Search more.